Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer

Skeletal metastasis occurs in around 75% of advanced breast cancers, with the disease incurable once cancer cells disseminate to bone, but there remains an unmet need for biomarkers to identify patients at high risk of bone recurrence. This study aimed to identify such a biomarker and to assess its...

Descripción completa

Detalles Bibliográficos
Autores principales: Westbrook, Jules A, Wood, Steven L, Cairns, David A, McMahon, Kathryn, Gahlaut, Renu, Thygesen, Helene, Shires, Mike, Roberts, Stephanie, Marshall, Helen, Oliva, Maria R, Dunning, Mark J, Hanby, Andrew M, Selby, Peter J, Speirs, Valerie, Mavria, Georgia, Coleman, Robert E, Brown, Janet E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618075/
https://www.ncbi.nlm.nih.gov/pubmed/30426503
http://dx.doi.org/10.1002/path.5197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618075/
https://www.ncbi.nlm.nih.gov/pubmed/30426503
http://dx.doi.org/10.1002/path.5197

Ejemplares similares